Trends in HIV post-exposure prophylaxis following sexual exposure in Brazil (2011–2019)

被引:0
作者
Kennedy Crepalde-Ribeiro
Juliana de Oliveira Costa
Sallie-Anne Pearson
Micheline Rosa Silveira
Jullye Campos Mendes
Simone Furtado dos Santos
Márcio Afonso Cruz
Maria das Graças Braga
机构
[1] Universidade Federal de Minas Gerais,Postgraduation Program in Medicines and Pharmaceutical Policy, Faculty of Pharmacy
[2] UNSW Sydney,School of Population Health, Faculty of Medicine and Health
[3] Universidade Federal de Minas Gerais,Department of Social Pharmacy, Faculty of Pharmacy
[4] Universidade FUMEC,Postgraduate Program in Information Systems and Knowledge Management
来源
AIDS and Behavior | 2022年 / 26卷
关键词
HIV prevention; Post-exposure prophylaxis; Nonoccupational postexposure prophylaxis; Sexual exposure;
D O I
暂无
中图分类号
学科分类号
摘要
We examined trends in the prevalence of post-exposure prophylaxis following sexual exposure (PEPSE) per million population (2011–2019) and the proportion of repeated PEPSE within 365 days of the first PEPSE dispensing (2011–2018) in Brazil. We also compared the prevalence of repeated PEPSE according to patient and health services characteristics in 2018. The prevalence of PEPSE increased 55.5% from 2011 to 2019. Repeated PEPSE increased 11.8%, reaching 8.4% among people with their first dispensing in 2018. The prevalence of repeated PEPSE was higher in cis men or trans women (versus cisgender women); homosexuals (versus heterosexuals); and people aged 25–29 years (versus other age groups). We also observed greater prevalence of repeated PEPSE in HIV services in populous cities or services with elevated caseloads. Our findings highlight the need for strategies to reduce repeated PEPSE and promote other HIV-prevention technologies, particularly among young adults, cisgender men, transgender women, and homosexuals.
引用
收藏
页码:4115 / 4125
页数:10
相关论文
共 99 条
  • [1] Henderson DK(1989)Prophylactic zidovudine after occupational exposure to the human immunodeficiency virus: an interim analysis J Infect Dis 160 321-7
  • [2] Gerberding JL(1997)A case-control study of HIV seroconversion in health care workers after percutaneous exposure N Engl J Med 337 1485-90
  • [3] Cardo DM(2004)Behavioral impact, acceptability, and HIV incidence among homosexual men with access to postexposure chemoprophylaxis for HIV J Acquir Immune Defic Syndr 35 519-25
  • [4] Culver DH(2015)Efficacy of HIV Postexposure Prophylaxis: Systematic Review and Meta-analysis of Nonhuman Primate Studies Clin Infect Dis 60 165-9
  • [5] Ciesielski CA(1996)Update: provisional Public Health Service recommendations for chemoprophylaxis after occupational exposure to HIV MMWR Morb Mortal Wkly Rep 45 468-80
  • [6] Schechter M(1998)Management of possible sexual, injecting-drug-use, or other nonoccupational exposure to HIV, including considerations related to antiretroviral therapy. Public Health Service statement MMWR Recomm Rep 47 1-14
  • [7] do Lago RF(2020)HIV Nonoccupational Postexposure Prophylaxis Among Men Who Have Sex with Men: A Systematic Review and Meta-Analysis of Global Data AIDS Patient Care STDS 34 193-204
  • [8] Mendelsohn AB(2019)Post-exposure prophylaxis following consented sexual exposure: impact of national recommendations on user profile, drug regimens and estimates of averted HIV infections HIV Med 21 240-5
  • [9] Irvine C(2014)Uptake and repeat use of postexposure prophylaxis in a community-based clinic in Los Angeles, California AIDS Res Hum Retroviruses 30 848-55
  • [10] Egan KJ(2017)High HIV incidence in men who have sex with men attending for postexposure prophylaxis: a service evaluation Sex Transm Infect 93 214-6